3Cao A, Galanello R, Rosatelli MC, et al. Clinical experience of management of β-thalassemia: The Sardinian experience. Semin Hematol. 1996,33 (1) : 70-- 75.
4Liu DP, Liang CC, Ao ZH, et al. Treatment of severe β-thalassemia(patients) with myleran. Am J Hematol, 1990, 33(1):50-55.
5Zhang J W，Sci China C，1996年，39卷，329页
6Blau C A，Blood，1993年，81期，529页
7Zhang J W，Development Genetics，1990年，11卷，168页
8Chui D H，Proc Nat Acad Sci SUA，1980年，77期，2757页
9Chui D，Cellular and Molecular Regulation of Hemoglobin Switching[M]，1979年，213226页
2Tuan D, Solomon W, Li Q, et al. The "β-like-globin" gene domain in human erythroid cells[J]. Proc Natl Acad Sci USA, 1985,82(19) :6384-6388.
3Grosvekd F, Van Assendelft GB, Greaves DR, et al. Position-independent high-level expression of the human β-globin gene in transgenic mice[J]. Cell, 1987,51 (6) :975-985.
4Ellis J, Talbot D, Dillon N, et al. Synthetic human β-globin 5'HS2 constructs function as locus control region only in multicopy trarsgene concatemers [ J ]. EMBO J, 1993,12 ( 1 ): 127-134.
5Caterina JJ, Ryan TM, Pawlik KM,et al. Human β-globin locus control region:analysis of the 5' DNase I hypersensitive site HS2 in transgenic mice[J]. Proc Natl Acad Sci USA, 1991,88(5): 1626-1630.
6David A,Jennifer C. β-globin locus control region HS2 and HS3 interact structurally and functionally[J ]. Nucleic Acids Res, 2003,31:1180-1190.
